The global opioid use disorder treatment market is on a promising growth path, with an expected valuation of US$ 3.07 billion in 2023. According to recent market analysis, the sector is projected to expand at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2033, ultimately reaching US$ 8.4 billion.
This remarkable growth is primarily fueled by an increasing number of treatment centers and strategic mergers with private recovery institutions aimed at enhancing access to treatment for a broader population. Additionally, heightened government initiatives and funding directed toward raising awareness and providing effective treatment for opioid use disorder are further expected to drive market expansion during the forecast period.
Key Market Drivers:
- Expansion of Treatment Centers: The proliferation of treatment centers, particularly those that collaborate with private recovery institutions, is making it easier for individuals to access essential treatment services. This trend is vital for addressing the growing opioid crisis and ensuring that more people receive the support they need.
- Government Initiatives and Funding: Increased government focus on combating opioid use disorder through initiatives and funding is significantly contributing to market growth. These efforts aim to enhance public awareness, improve treatment options, and reduce stigma associated with seeking help.
- Rising Awareness of Opioid Use Disorder: As awareness of the opioid crisis grows, more individuals are recognizing the importance of treatment. This shift in perception is encouraging more people to seek help, thus driving demand for effective treatment options.
Regional Insights: North America is expected to dominate the opioid use disorder treatment market, driven by a high prevalence of opioid addiction and robust government support for treatment programs. Europe is also projected to play a significant role, while the Asia-Pacific region is anticipated to experience rapid growth as awareness and treatment resources improve.
Market Outlook: As the opioid crisis continues to challenge healthcare systems worldwide, the opioid use disorder treatment market is poised for substantial growth over the next decade. With a focus on expanding access to treatment and increased government support, the market is set to make significant strides in addressing this critical public health issue by 2033.
Which are Some Prominent Drivers of the Opioid use disorder treatment market?
Adoption of buprenorphine patches propelling market expansion
The increasing consideration of buprenorphine patches as an effective treatment mode is fueling the market growth. Buprenorphine patches are becoming gradually popular as an effective treatment for opioid use disorder, which is expected to propel opioid use disorder market. These patches containing buprenorphine are regarded as a cutting-edge method for treating these disorders.
Likewise, transdermal patches offer numerous benefits over other kinds of treatment, such as injections, including the most pleasant drug delivery system, excellent pain relief, and self-administration of drug. Also, growing adoption of key strategies such as collaboration, acquisition, agreement, and partnership by opioid industry of opioids use disorder is leading to market expansion. For example, in February 2019, Indivior PLC, a pharmaceutical company, made a revelation about an agreement with Alvogen Pine Brook LLC, a pharmaceutical company for sell of generic buprenorphine and naloxone sublingual film product.
Market Competition
The opioid use disorder treatment market is competitive and consists of several major players. Major players are creating novel delivery systems for the treatment of Opioid use disorder. This is expected to propel Opioid use disorder treatment market. The major players in the market are: Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., BioDelivery Sciences International, Inc. Key market players are concentrating on adoption of inorganic growth strategies such as acquisition, partnerships, and collaboration in order to improve their product portfolio. This is expected to propel the global Opioid use disorder treatment market.
Some recent developments in the market are:
- In January 2022, Trevena, Inc. declared that China’s National Medical Products Administration (NMPA) has accepted the submission of a New Drug Application (NDA) for OLINVYK (oliceridine) injection, a novel IV analgesic that has been approved in the United States by the FDA for use in adults for managing acute pain severe enough to require an intravenous opioid analgesic.
- In October 2021, Esteve Pharmaceuticals received authorisation from the United States Food and Drug Administration (FDA) for SEGLENTIS (celecoxib and tramadol hydrochloride) for the management of acute pain in adults that is extreme enough to require an opioid analgesic.
- In January 2020, Titan Pharmaceuticals, Inc. made a revelation that they had entered into an agreement with AllianceRx Walgreens Prime for the expansion of accessibility of patients for Titan’s opioid use disorder implant branded as “Probuphine implant”.
Key Companies Profiled
- Trevena
- Opiate Pharmaceutical
- Aphios
- Kyowa kirin
- Gamida-Cell
- Novartis AG
- Titan Pharmaceuticals, Inc.
- Hikma Pharmaceuticals
- MediciNova
- Alkermes, Inc.
- BioDelivery Sciences International Inc.
Key Segments Profiled in the Opioid Use Disorder Treatment Market Survey
By Drug Type:
- Romiplostim
- Omidubicel
- Nalmefene
- Buprenorfine
- Methadone
- Naltrexone
By Route of Administration:
- Oral
- Parenteral
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
